- IN₹8.77bn
- IN₹10.23bn
- IN₹6.81bn
Brief: Kopran Says Unit Acquired Assets Of Manufacturing Unit Of Abhinandan Rasayan
Brief: India's Kopran June-Qtr Consol Net Profit Rises
Brief: Kopran Dec-Quarter Consol Net Profit Rises
Brief: Kopran To Consider Issue Of Equity Shares On Preferential Basis
Sept-Quarter Consol Net Profit Rises
Brief: Kopran March-Quarter Consol Net Profit Rises
Brief: India's Kopran Says Dec-Quarter Consol Profit Rises
Brief: India's Kopran June Qtr Consol Profit Rises
Brief: India's Kopran March-Quarter Consol Profit Falls
Brief: Kopran Says USFDA Approved Drug Master File Of Atenolol
Brief: India's Kopran Dec Quarter Consol Profit Falls
Brief: Kopran To Consider Early Redemption Of Preference Shares
Brief: India's Kopran June-Qtr Profit Rises
Brief: India's Kopran March-Qtr Consol Profit Rises
Brief: Kopran Says No 483 Observations Issued By USFDA After Inspection Of Co's Madad Facility
Brief: India's Kopran Dec-Qtr Consol Profit Rises
Brief: India's Kopran Sept-Qtr Profit Falls
Brief: India's Kopran June-Qtr Consol Profit Rises
Brief: Kopran Says Unit Acquired API Facility At Panoli, Gujarat